Gcm2 expression in PTGs is significantly decreased at the early stage of CKD even if there is no significant change in CaSR and VDR expression, no decrease in active vitamin D, and levels of Ca and Pi are normal which is a result of significant PTH elevation. The gene discussed is CASR; the disease is chronic kidney disease.